Can I give 60,000 units of vitamin D3 (Vitamin D3) per week for plantar fasciitis, Achilles tendinosis, and bursitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin D3 Supplementation for Plantar Fasciitis, Achilles Tendinosis, and Bursitis

Weekly vitamin D3 supplementation of 60,000 IU is not recommended for plantar fasciitis, Achilles tendinosis, or bursitis, as this exceeds safe dosing guidelines and there is no evidence supporting vitamin D specifically for these musculoskeletal conditions. 1

Appropriate Vitamin D Supplementation

The American College of Nutrition and American Heart Association recommend much lower doses of vitamin D:

  • Adults (1-70 years): 600-800 IU daily 1
  • Adults over 70 years: 800 IU daily 1
  • Safe upper limit: 4,000 IU daily 1

A weekly dose of 60,000 IU equals approximately 8,571 IU per day, which exceeds the recommended safe upper limit by more than double.

Special Populations Requiring Higher Doses

Some populations may require higher doses, but still not as high as 60,000 IU weekly:

  • Patients with obesity: 2-3 times higher doses (up to 7,000 IU daily) 1
  • Patients with malabsorption syndromes: higher doses or weekly regimens 1
  • Patients with liver disease: higher doses due to impaired hepatic 25-hydroxylation 1

Safety Considerations

While one study suggests that long-term supplementation with vitamin D3 in doses ranging from 5,000 to 50,000 IU/day appears to be safe in hospitalized patients 2, this contradicts established guidelines and was conducted in a controlled hospital environment with regular monitoring.

For vitamin D deficiency treatment:

  • For levels 5-15 ng/mL: 50,000 IU weekly for 4-8 weeks, then maintenance 1
  • After reaching target levels, maintenance doses should be reduced to guideline-recommended amounts

Evidence for Musculoskeletal Conditions

There is no evidence supporting vitamin D supplementation specifically for:

  • Plantar fasciitis
  • Achilles tendinosis
  • Bursitis

The standard treatments for these conditions include:

Plantar Fasciitis

  • Conservative measures: rest, ice, NSAIDs, stretching exercises, orthotics, night splints 3, 4
  • Addressing biomechanical issues: controlling pronation, proper footwear 4
  • More advanced treatments: steroid injections, extracorporeal shock wave therapy 5

Achilles Tendinosis and Bursitis

  • Rest, ice, NSAIDs, physical therapy 5
  • Addressing biomechanical issues and training errors 4
  • Novel treatments may include injection therapy for recalcitrant cases 5

Monitoring Recommendations

If vitamin D supplementation is used (at appropriate doses):

  • Check vitamin D levels after 3 months to ensure target level has been reached 1
  • Monitor annually once stable 1
  • Target serum 25(OH)D level: 30-80 ng/mL 1
  • Monitor serum calcium and phosphorus with higher doses 1

Bottom Line

The proposed weekly dose of 60,000 IU vitamin D3 is excessive and not indicated for plantar fasciitis, Achilles tendinosis, or bursitis. Focus instead on evidence-based treatments for these specific conditions and consider appropriate vitamin D supplementation only if deficiency is documented.

References

Guideline

Vitamin D Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Plantar Fasciitis: Diagnosis and Conservative Management.

The Journal of the American Academy of Orthopaedic Surgeons, 1997

Research

Plantar fasciitis in runners. Treatment and prevention.

Sports medicine (Auckland, N.Z.), 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.